Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI-Next-gen. testing/urveillance techn.

University of Toronto

$200,000.00

A low-cost diagnostic for improving access to Neisseria gonorrhoeae screening and antimicrobial resistance monitoring in Canada and Uganda

EF 2024-25

Résumé
The World Health Organization (WHO) has identified an urgent need for a new low cost and rapid diagnostic to test for Neisseria gonorrhoeae (NG) and detect if it has genetic markers of antimicrobial resistance (AMR). This sexually transmitted infection (STI) affects 87 million people worldwide each year and if left untreated can lead to serious health effects like reproductive and pregnancy complications as well as an increased risk of HIV. STIs and associated health complications disproportionately affect marginalized and vulnerable populations, including in resource-constrained settings. This project will take an innovative interdisciplinary approach to developing a diagnostic platform to fill this gap while concurrently identifying and understanding barriers to NG testing with the aim of improving access to testing and appropriate AMR treatment in Canada and Uganda. We will demonstrate a proof-of-concept for a rapid and low-cost lateral flow diagnostic with high sensitivity and specificity detection of NG that meets WHO criteria and take the first steps towards developing a companion mobile health platform to support the test use and interpretation. Concurrently, we will work with partners in Canada and in Kampala, Uganda to conduct a qualitative study with key stakeholders and healthcare workers to gather information on implementation and usability of the NG test within the context of current sexual and reproductive health services. This project will be rooted in strong partnerships in Uganda to ensure positive social impact in the community including with Ugandan researchers, Ugandan Ministry of Health and academics.
Programme
Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI-Next-gen. testing/urveillance techn.
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
521676
Name
Weckman Nicole E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant : Biomedical Research for HIV/AIDS and STBBI
Projecttitle
A low-cost diagnostic for improving access to Neisseria gonorrhoeae screening and antimicrobial resistance monitoring in Canada and Uganda
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$200,000
Cihrequipment2
$0
Programname2
Ca. Gr.: Biomedical Res. for HIV/AIDS/STBBI-Next-gen. testing/urveillance techn.
Keyworddelim
Diagnostics; Digital Health; Global Health; Neisseria Gonorrhoeae; Sexually Transmitted Infections
Abstract
The World Health Organization (WHO) has identified an urgent need for a new low cost and rapid diagnostic to test for Neisseria gonorrhoeae (NG) and detect if it has genetic markers of antimicrobial resistance (AMR). This sexually transmitted infection (STI) affects 87 million people worldwide each year and if left untreated can lead to serious health effects like reproductive and pregnancy complications as well as an increased risk of HIV. STIs and associated health complications disproportionately affect marginalized and vulnerable populations, including in resource-constrained settings. This project will take an innovative interdisciplinary approach to developing a diagnostic platform to fill this gap while concurrently identifying and understanding barriers to NG testing with the aim of improving access to testing and appropriate AMR treatment in Canada and Uganda. We will demonstrate a proof-of-concept for a rapid and low-cost lateral flow diagnostic with high sensitivity and specificity detection of NG that meets WHO criteria and take the first steps towards developing a companion mobile health platform to support the test use and interpretation. Concurrently, we will work with partners in Canada and in Kampala, Uganda to conduct a qualitative study with key stakeholders and healthcare workers to gather information on implementation and usability of the NG test within the context of current sexual and reproductive health services. This project will be rooted in strong partnerships in Uganda to ensure positive social impact in the community including with Ugandan researchers, Ugandan Ministry of Health and academics.
Competitiondate
202410
Approvedterm2
1 yr 0 mth
Pinamesdelim
Weckman, Nicole E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $200,000~ $0~